2-107987811-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_021815.5(SLC5A7):​c.-51-294A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.042 in 152,294 control chromosomes in the GnomAD database, including 166 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.042 ( 166 hom., cov: 33)

Consequence

SLC5A7
NM_021815.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.179

Publications

1 publications found
Variant links:
Genes affected
SLC5A7 (HGNC:14025): (solute carrier family 5 member 7) This gene encodes a sodium ion- and chloride ion-dependent high-affinity transporter that mediates choline uptake for acetylcholine synthesis in cholinergic neurons. The protein transports choline from the extracellular space into presynaptic terminals for synthesis into acetylcholine. Increased choline uptake results from increased density of this protein in synaptosomal plasma membranes in response to depolarization of cholinergic terminals. Dysfunction of cholinergic signaling has been implicated in various disorders including depression, attention-deficit disorder, and schizophrenia. An allelic variant of this gene is associated with autosomal dominant distal hereditary motor neuronopathy type VIIA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
SLC5A7 Gene-Disease associations (from GenCC):
  • neuronopathy, distal hereditary motor, type 7A
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 20
    Inheritance: AR Classification: STRONG Submitted by: G2P, Ambry Genetics, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • distal hereditary motor neuropathy type 7
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 2-107987811-A-G is Benign according to our data. Variant chr2-107987811-A-G is described in ClinVar as [Benign]. Clinvar id is 1227315.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.108 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC5A7NM_021815.5 linkc.-51-294A>G intron_variant Intron 1 of 8 ENST00000264047.3 NP_068587.1 Q9GZV3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC5A7ENST00000264047.3 linkc.-51-294A>G intron_variant Intron 1 of 8 1 NM_021815.5 ENSP00000264047.2 Q9GZV3
SLC5A7ENST00000409059.5 linkc.-48-297A>G intron_variant Intron 1 of 8 1 ENSP00000387346.1 Q9GZV3

Frequencies

GnomAD3 genomes
AF:
0.0421
AC:
6400
AN:
152176
Hom.:
166
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0362
Gnomad AMI
AF:
0.0987
Gnomad AMR
AF:
0.0417
Gnomad ASJ
AF:
0.0461
Gnomad EAS
AF:
0.0327
Gnomad SAS
AF:
0.117
Gnomad FIN
AF:
0.0527
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0383
Gnomad OTH
AF:
0.0473
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0420
AC:
6389
AN:
152294
Hom.:
166
Cov.:
33
AF XY:
0.0443
AC XY:
3295
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0361
AC:
1500
AN:
41552
American (AMR)
AF:
0.0416
AC:
636
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0461
AC:
160
AN:
3472
East Asian (EAS)
AF:
0.0324
AC:
168
AN:
5182
South Asian (SAS)
AF:
0.116
AC:
558
AN:
4822
European-Finnish (FIN)
AF:
0.0527
AC:
559
AN:
10614
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0383
AC:
2604
AN:
68028
Other (OTH)
AF:
0.0478
AC:
101
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
299
597
896
1194
1493
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0398
Hom.:
200
Bravo
AF:
0.0373
Asia WGS
AF:
0.0820
AC:
283
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Oct 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
14
DANN
Benign
0.37
PhyloP100
0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17036563; hg19: chr2-108604267; API